Nuformix (LSE:NFX) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nuformix's Free Cash Flow for the six months ended in Mar. 2024 was £-0.17 Mil. Nuformix's Revenue for the six months ended in Mar. 2024 was £0.00 Mil. Therefore, Nuformix's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Nuformix's current FCF Yield % is -18.59%.

The historical rank and industry rank for Nuformix's FCF Margin % or its related term are showing as below:

LSE:NFX' s FCF Margin % Range Over the Past 10 Years
Min: -10880 Med: -431.63 Max: -53.44
Current: -338

During the past 6 years, the highest FCF Margin % of Nuformix was -53.44%. The lowest was -10880.00%. And the median was -431.63%.

LSE:NFX's FCF Margin % is ranked worse than
61.72% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs LSE:NFX: -338.00

Nuformix FCF Margin % Historical Data

The historical data trend for Nuformix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix FCF Margin % Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

FCF Margin %

Get a 7-Day Free Trial

-10,880.00

-53.44

-142.24

-431.63

-2,692.00

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24
FCF Margin %	Get a 7-Day Free Trial										-1,196.00	-	-	-	-

Competitive Comparison of Nuformix's FCF Margin %

For the Biotechnology subindustry, Nuformix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuformix's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nuformix's FCF Margin % falls into.

Nuformix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nuformix's FCF Margin for the fiscal year that ended in Mar. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2022 )	/	Revenue (A: Mar. 2022 )
	=	-1.346	/	0.05
	=	-2,692.00 %

Nuformix's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.169	/	0
	=	%

Nuformix FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nuformix's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.